11/21
03:09 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
11/20
11:12 am
vrtx
CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell? [Yahoo! Finance]
Low
Report
CRISPR Therapeutics Stock Falls 7% in Two Weeks: Time to Hold or Sell? [Yahoo! Finance]
11/20
07:17 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate [Yahoo! Finance]
11/19
08:20 am
vrtx
SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension [Yahoo! Finance]
Medium
Report
SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension [Yahoo! Finance]
11/15
06:05 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
11/15
06:02 am
vrtx
Where Will CRISPR Therapeutics Be in 3 Years? [Yahoo! Finance]
Low
Report
Where Will CRISPR Therapeutics Be in 3 Years? [Yahoo! Finance]
11/14
10:01 am
vrtx
Citi initiates coverage on 5 new biotech stocks [Yahoo! Finance]
Low
Report
Citi initiates coverage on 5 new biotech stocks [Yahoo! Finance]
11/14
08:09 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $575.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $575.00 price target on the stock.
11/13
04:32 am
vrtx
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity [Yahoo! Finance]
Low
Report
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity [Yahoo! Finance]
11/13
03:02 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
11/12
02:16 pm
vrtx
Immigrant Workers Scramble To Secure Visas Ahead Of Trump's Inauguration [Forbes]
Low
Report
Immigrant Workers Scramble To Secure Visas Ahead Of Trump's Inauguration [Forbes]
11/12
09:56 am
vrtx
Meet America's Best Companies 2025 [Forbes]
Low
Report
Meet America's Best Companies 2025 [Forbes]
11/12
08:44 am
vrtx
Optimus SBR Welcomes Ken Chan as the New Partner and Practice Leader for Health, Government and Public Sector [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Optimus SBR Welcomes Ken Chan as the New Partner and Practice Leader for Health, Government and Public Sector [Globe and Mail, The (Toronto, Canada)]
11/8
10:59 am
vrtx
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
11/6
01:10 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $361.00 to $408.00. They now have a "sell" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $361.00 to $408.00. They now have a "sell" rating on the stock.
11/6
11:24 am
vrtx
Vertex Pharmaceuticals (VRTX) Just Overtook the 20-Day Moving Average [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Just Overtook the 20-Day Moving Average [Yahoo! Finance]
11/6
11:24 am
vrtx
Vertex Pharmaceuticals (VRTX) Crossed Above the 50-Day Moving Average: What That Means for Investors [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Crossed Above the 50-Day Moving Average: What That Means for Investors [Yahoo! Finance]
11/5
11:06 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/5
08:14 pm
vrtx
Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Low
Report
Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
11/5
07:44 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Scotiabank from $480.00 to $486.00. They now have a "sector perform" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Scotiabank from $480.00 to $486.00. They now have a "sector perform" rating on the stock.
11/5
02:14 pm
vrtx
Editas Medicine Downgraded by Raymond James Amid Strategic Shift and Program Uncertainty [Yahoo! Finance]
Low
Report
Editas Medicine Downgraded by Raymond James Amid Strategic Shift and Program Uncertainty [Yahoo! Finance]
11/5
01:49 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at UBS Group AG from $562.00 to $586.00. They now have a "buy" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at UBS Group AG from $562.00 to $586.00. They now have a "buy" rating on the stock.
11/5
12:33 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Royal Bank of Canada from $437.00 to $451.00. They now have a "sector perform" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Royal Bank of Canada from $437.00 to $451.00. They now have a "sector perform" rating on the stock.
11/5
12:33 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $480.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $480.00 price target on the stock.
11/5
11:36 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $510.00 to $503.00. They now have an "overweight" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $510.00 to $503.00. They now have an "overweight" rating on the stock.